Peter Wagner
Gründer bei S2 Genomics, Inc.
Profil
Peter Wagner was the founder of Zyomyx, Inc. (founded in 1998) where he held the title of President & Chief Executive Officer from 2010 to 2013.
He is also the founder of S2 Genomics, Inc. (founded in 2016) where he currently holds the title of Director.
Dr. Wagner's current job is as the Chief Executive Officer, CFO & Secretary at Fluxus Inc. Dr. Wagner's education includes a graduate degree from Eberhard Karls Universität Tübingen, a doctorate degree from Swiss Federal Institute of Technology, and a graduate degree from the University of Hohenheim.
Aktive Positionen von Peter Wagner
| Unternehmen | Position | Beginn |
|---|---|---|
S2 Genomics, Inc.
 S2 Genomics, Inc. BiotechnologyHealth Technology S2 Genomics, Inc. develops laboratory automation solutions for processing solid tissues for life science applications. The company was founded by Stevan Jovanovich, Peter Wagner, Shannon Hall and Roger McIntosh in 2016 and is headquartered in Livermore, CA. | Gründer | 01.01.2016 |
Fluxus Inc
 Fluxus Inc Miscellaneous Commercial ServicesCommercial Services Part of H.U. Group Holdings, Inc., Fluxus Inc engages in biological research business. The company is based in Santa Clara, CA. The CEO of the company is Peter Wagner. Fluxus was acquired by Fujirebio Holdings, Inc. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Peter Wagner
| Unternehmen | Position | Ende |
|---|---|---|
Zyomyx, Inc.
 Zyomyx, Inc. Medical SpecialtiesHealth Technology Zyomyx, Inc. manufactured point-of-care diagnostic devices based on cell-counting technology. It engaged in the development and commercialization of diagnostic platforms. The firm offered disposable CD4 T-cell, a point-of-care test for HIV and AIDS treatment. The company was founded by Peter Wagner, Steffen Nock, Christian Itin, and Dana Ault-Riche in 1998 and was headquartered in Fremont, CA. | Vorstandsvorsitzender | - |
Ausbildung von Peter Wagner
| Eberhard Karls Universität Tübingen | Graduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
| University of Hohenheim | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Zyomyx, Inc.
Zyomyx, Inc. Medical SpecialtiesHealth Technology Zyomyx, Inc. manufactured point-of-care diagnostic devices based on cell-counting technology. It engaged in the development and commercialization of diagnostic platforms. The firm offered disposable CD4 T-cell, a point-of-care test for HIV and AIDS treatment. The company was founded by Peter Wagner, Steffen Nock, Christian Itin, and Dana Ault-Riche in 1998 and was headquartered in Fremont, CA. | Health Technology |
S2 Genomics, Inc.
S2 Genomics, Inc. BiotechnologyHealth Technology S2 Genomics, Inc. develops laboratory automation solutions for processing solid tissues for life science applications. The company was founded by Stevan Jovanovich, Peter Wagner, Shannon Hall and Roger McIntosh in 2016 and is headquartered in Livermore, CA. | Health Technology |
Fluxus Inc
Fluxus Inc Miscellaneous Commercial ServicesCommercial Services Part of H.U. Group Holdings, Inc., Fluxus Inc engages in biological research business. The company is based in Santa Clara, CA. The CEO of the company is Peter Wagner. Fluxus was acquired by Fujirebio Holdings, Inc. | Commercial Services |
